N-(5-(4-(3-(Diethylamino)propyl)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-2-methoxypyridin-3-yl)butane-1-sulfonamide

ID: ALA4250377

PubChem CID: 145984858

Max Phase: Preclinical

Molecular Formula: C25H36N4O5S

Molecular Weight: 504.65

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCS(=O)(=O)Nc1cc(-c2ccc3c(c2)N(CCCN(CC)CC)C(=O)CO3)cnc1OC

Standard InChI:  InChI=1S/C25H36N4O5S/c1-5-8-14-35(31,32)27-21-15-20(17-26-25(21)33-4)19-10-11-23-22(16-19)29(24(30)18-34-23)13-9-12-28(6-2)7-3/h10-11,15-17,27H,5-9,12-14,18H2,1-4H3

Standard InChI Key:  HLHKYPLDDUVEDJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 35 37  0  0  0  0  0  0  0  0999 V2000
   10.4543  -19.1586    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8670  -18.4528    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.0494  -18.4483    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8711  -20.0913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8711  -20.9085    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5764  -21.3130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2817  -20.9085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2817  -20.0913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5764  -19.6786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9883  -21.3216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9852  -22.1397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6882  -22.5492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6945  -20.9129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4021  -21.3270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3955  -22.1468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0982  -22.5602    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8121  -22.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8188  -21.3385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1115  -20.9205    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5302  -20.9363    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5764  -18.8614    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1622  -19.6848    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4557  -20.0955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1170  -20.1034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8274  -19.6995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8329  -18.8823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5433  -18.4785    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2504  -18.8971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9587  -18.4967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2636  -17.2637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5491  -17.6657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8629  -17.6356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5685  -17.2235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5644  -16.4063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2700  -15.9941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
 10 11  1  0
 10 13  2  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
  7 10  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
  9 21  1  0
 21  2  1  0
  4 22  1  0
 22 23  1  0
 19 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 31  1  0
 28 29  1  0
 30 31  1  0
  2 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4250377

    ---

Associated Targets(Human)

SNU-638 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 504.65Molecular Weight (Monoisotopic): 504.2406AlogP: 3.76#Rotatable Bonds: 13
Polar Surface Area: 101.07Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.88CX Basic pKa: 9.84CX LogP: 0.90CX LogD: 0.28
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.44Np Likeness Score: -1.64

References

1. Dong FD, Liu DD, Deng CL, Qin XC, Chen K, Wang J, Song HR, Ding HW..  (2018)  Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors.,  26  (14): [PMID:29937355] [10.1016/j.bmc.2018.06.022]

Source